Hungary's Richter sees extension of use of its Esmya drug in EU

April 27, 2015 6:52 AM

16 0

BUDAPEST, April 27 (Reuters) - The European Medicines Agency (EMA) has positively assessed Richter's application to extend the indication of its Esmya tablets to the long-term treatment of symptoms of uterine fibroids, the Hungarian drug maker said on Monday.

Richter makes gynecological, cardiovascular and central nervous system drugs.

Read more

To category page